Global Extracorporeal Membrane Oxygenation Machine

Extracorporeal Membrane Oxygenation Machine Comprehensive Study by Type (VA ECMO Machine, VV ECMO Machine), Application (Congenital diaphragmatic hernia (CDH), Birth defects of the heart, Meconium aspiration syndrome (MAS), Severe pneumonia, Severe air leak problems, Severe high blood pressure in the arteries of the lungs (PPHN)), Patient Type (Neonates, Pediatric, Adult) Players and Region - Global Market Outlook to 2030

Extracorporeal Membrane Oxygenation Machine Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Extracorporeal Membrane Oxygenation Machine
Extracorporeal membrane oxygenation (ECMO) machines used to pump and oxygenate a patient's blood outside the body, allowing the heart and lungs to rest. These machines are similar to heart-lung bypass machines used during open-heart surgery. These machines used for patients recovering from heart failure, or lung failure or heart surgery, support during high-risk procedures in the cardiac catheterization lab, as a bridge to heart assist devices, such as left ventricular assist device (LVAD), and other purposes.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Extracorporeal Membrane Oxygenation Machine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic plc (Ireland), Getinge Group (Sweden), Terumo Corporation (Japan), LivaNova PLC (United Kingdom), XENIOS AG (Germany), ALung Technologies, Inc. (Germany), EUROSETS S.r.l. (Italy), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan) and OriGen Biomedical, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are EUROSETS NIPRO (Japan), MicroPort Scientific Corporation (China), Maquet Holding GmbH & Co. KG (Germany), Terumo Corporation (Japan) and LivaNova PLC (United Kingdom).

Segmentation Overview
AMA Research has segmented the market of Global Extracorporeal Membrane Oxygenation Machine market by Type (VA ECMO Machine and VV ECMO Machine), Application (Congenital diaphragmatic hernia (CDH), Birth defects of the heart, Meconium aspiration syndrome (MAS), Severe pneumonia, Severe air leak problems and Severe high blood pressure in the arteries of the lungs (PPHN)) and Region.



On the basis of geography, the market of Extracorporeal Membrane Oxygenation Machine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Patient Type, the sub-segment i.e. Neonates will boost the Extracorporeal Membrane Oxygenation Machine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Demand for Portable ECMO Machine

Market Growth Drivers:
Increased Prevalence of Cardiovascular and Respiratory Diseases and Increased Number of ECMO Centres

Challenges:
Lack of Skilled Professionals

Restraints:
Risk Associated with Extracorporeal Membrane Oxygenation Machine such as Bleeding, Blood Clot Forming and Infection

Opportunities:
Increasing Applications of ECMO Machines and Technological Advancements in the ECMO Machines

Market Leaders and their expansionary development strategies
In November 2023, A consortium of ECMO manufacturers, healthcare providers, and patient advocacy groups joined forces to establish standardized training protocols and best practices for ECMO therapy, ensuring optimal patient care and safety across different institutions.
In October 2023, LivaNova launched its "PHLAPS HF" portable ECMO system, designed for rapid deployment and early intervention in patients with heart failure, potentially improving survival rates.


Key Target Audience
Extracorporeal Membrane Oxygenation Machine Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • VA ECMO Machine
  • VV ECMO Machine
By Application
  • Congenital diaphragmatic hernia (CDH)
  • Birth defects of the heart
  • Meconium aspiration syndrome (MAS)
  • Severe pneumonia
  • Severe air leak problems
  • Severe high blood pressure in the arteries of the lungs (PPHN)
By Patient Type
  • Neonates
  • Pediatric
  • Adult

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Cardiovascular and Respiratory Diseases
      • 3.2.2. Increased Number of ECMO Centres
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Portable ECMO Machine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Extracorporeal Membrane Oxygenation Machine, by Type, Application, Patient Type and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Extracorporeal Membrane Oxygenation Machine (Value)
      • 5.2.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Value)
        • 5.2.1.1. VA ECMO Machine
        • 5.2.1.2. VV ECMO Machine
      • 5.2.2. Global Extracorporeal Membrane Oxygenation Machine by: Application (Value)
        • 5.2.2.1. Congenital diaphragmatic hernia (CDH)
        • 5.2.2.2. Birth defects of the heart
        • 5.2.2.3. Meconium aspiration syndrome (MAS)
        • 5.2.2.4. Severe pneumonia
        • 5.2.2.5. Severe air leak problems
        • 5.2.2.6. Severe high blood pressure in the arteries of the lungs (PPHN)
      • 5.2.3. Global Extracorporeal Membrane Oxygenation Machine by: Patient Type (Value)
        • 5.2.3.1. Neonates
        • 5.2.3.2. Pediatric
        • 5.2.3.3. Adult
      • 5.2.4. Global Extracorporeal Membrane Oxygenation Machine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Extracorporeal Membrane Oxygenation Machine (Volume)
      • 5.3.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Volume)
        • 5.3.1.1. VA ECMO Machine
        • 5.3.1.2. VV ECMO Machine
      • 5.3.2. Global Extracorporeal Membrane Oxygenation Machine by: Application (Volume)
        • 5.3.2.1. Congenital diaphragmatic hernia (CDH)
        • 5.3.2.2. Birth defects of the heart
        • 5.3.2.3. Meconium aspiration syndrome (MAS)
        • 5.3.2.4. Severe pneumonia
        • 5.3.2.5. Severe air leak problems
        • 5.3.2.6. Severe high blood pressure in the arteries of the lungs (PPHN)
      • 5.3.3. Global Extracorporeal Membrane Oxygenation Machine by: Patient Type (Volume)
        • 5.3.3.1. Neonates
        • 5.3.3.2. Pediatric
        • 5.3.3.3. Adult
      • 5.3.4. Global Extracorporeal Membrane Oxygenation Machine Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Extracorporeal Membrane Oxygenation Machine (Price)
      • 5.4.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Price)
  • 6. Extracorporeal Membrane Oxygenation Machine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Getinge Group (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Terumo Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. LivaNova PLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. XENIOS AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ALung Technologies, Inc. (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. EUROSETS S.r.l. (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MicroPort Scientific Corporation (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NIPRO Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. OriGen Biomedical, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Extracorporeal Membrane Oxygenation Machine Sale, by Type, Application, Patient Type and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Extracorporeal Membrane Oxygenation Machine (Value)
      • 7.2.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Value)
        • 7.2.1.1. VA ECMO Machine
        • 7.2.1.2. VV ECMO Machine
      • 7.2.2. Global Extracorporeal Membrane Oxygenation Machine by: Application (Value)
        • 7.2.2.1. Congenital diaphragmatic hernia (CDH)
        • 7.2.2.2. Birth defects of the heart
        • 7.2.2.3. Meconium aspiration syndrome (MAS)
        • 7.2.2.4. Severe pneumonia
        • 7.2.2.5. Severe air leak problems
        • 7.2.2.6. Severe high blood pressure in the arteries of the lungs (PPHN)
      • 7.2.3. Global Extracorporeal Membrane Oxygenation Machine by: Patient Type (Value)
        • 7.2.3.1. Neonates
        • 7.2.3.2. Pediatric
        • 7.2.3.3. Adult
      • 7.2.4. Global Extracorporeal Membrane Oxygenation Machine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Extracorporeal Membrane Oxygenation Machine (Volume)
      • 7.3.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Volume)
        • 7.3.1.1. VA ECMO Machine
        • 7.3.1.2. VV ECMO Machine
      • 7.3.2. Global Extracorporeal Membrane Oxygenation Machine by: Application (Volume)
        • 7.3.2.1. Congenital diaphragmatic hernia (CDH)
        • 7.3.2.2. Birth defects of the heart
        • 7.3.2.3. Meconium aspiration syndrome (MAS)
        • 7.3.2.4. Severe pneumonia
        • 7.3.2.5. Severe air leak problems
        • 7.3.2.6. Severe high blood pressure in the arteries of the lungs (PPHN)
      • 7.3.3. Global Extracorporeal Membrane Oxygenation Machine by: Patient Type (Volume)
        • 7.3.3.1. Neonates
        • 7.3.3.2. Pediatric
        • 7.3.3.3. Adult
      • 7.3.4. Global Extracorporeal Membrane Oxygenation Machine Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Extracorporeal Membrane Oxygenation Machine (Price)
      • 7.4.1. Global Extracorporeal Membrane Oxygenation Machine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Extracorporeal Membrane Oxygenation Machine: by Type(USD Million)
  • Table 2. Extracorporeal Membrane Oxygenation Machine VA ECMO Machine , by Region USD Million (2018-2023)
  • Table 3. Extracorporeal Membrane Oxygenation Machine VV ECMO Machine , by Region USD Million (2018-2023)
  • Table 4. Extracorporeal Membrane Oxygenation Machine: by Application(USD Million)
  • Table 5. Extracorporeal Membrane Oxygenation Machine Congenital diaphragmatic hernia (CDH) , by Region USD Million (2018-2023)
  • Table 6. Extracorporeal Membrane Oxygenation Machine Birth defects of the heart , by Region USD Million (2018-2023)
  • Table 7. Extracorporeal Membrane Oxygenation Machine Meconium aspiration syndrome (MAS) , by Region USD Million (2018-2023)
  • Table 8. Extracorporeal Membrane Oxygenation Machine Severe pneumonia , by Region USD Million (2018-2023)
  • Table 9. Extracorporeal Membrane Oxygenation Machine Severe air leak problems , by Region USD Million (2018-2023)
  • Table 10. Extracorporeal Membrane Oxygenation Machine Severe high blood pressure in the arteries of the lungs (PPHN) , by Region USD Million (2018-2023)
  • Table 11. Extracorporeal Membrane Oxygenation Machine: by Patient Type(USD Million)
  • Table 12. Extracorporeal Membrane Oxygenation Machine Neonates , by Region USD Million (2018-2023)
  • Table 13. Extracorporeal Membrane Oxygenation Machine Pediatric , by Region USD Million (2018-2023)
  • Table 14. Extracorporeal Membrane Oxygenation Machine Adult , by Region USD Million (2018-2023)
  • Table 15. South America Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2018-2023)
  • Table 16. South America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 17. South America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 18. South America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 19. Brazil Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 20. Brazil Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 21. Brazil Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 22. Argentina Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 23. Argentina Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 24. Argentina Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 25. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 27. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 28. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 31. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 32. China Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 33. China Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 34. China Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 35. Japan Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 36. Japan Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 37. Japan Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 38. India Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 39. India Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 40. India Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 41. South Korea Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 42. South Korea Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 43. South Korea Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 44. Taiwan Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 45. Taiwan Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 46. Taiwan Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 47. Australia Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 48. Australia Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 49. Australia Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 53. Europe Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2018-2023)
  • Table 54. Europe Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 55. Europe Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 56. Europe Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 57. Germany Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 58. Germany Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 59. Germany Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 60. France Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 61. France Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 62. France Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 63. Italy Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 64. Italy Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 65. Italy Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 66. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 68. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 69. Netherlands Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 70. Netherlands Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 71. Netherlands Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 72. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 74. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 75. MEA Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2018-2023)
  • Table 76. MEA Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 77. MEA Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 78. MEA Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 79. Middle East Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 80. Middle East Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 81. Middle East Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 82. Africa Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 83. Africa Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 84. Africa Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 85. North America Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2018-2023)
  • Table 86. North America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 87. North America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 88. North America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 89. United States Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 90. United States Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 91. United States Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 92. Canada Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 93. Canada Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 94. Canada Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 95. Mexico Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2018-2023)
  • Table 96. Mexico Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2018-2023)
  • Table 97. Mexico Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2018-2023)
  • Table 98. Extracorporeal Membrane Oxygenation Machine Sales: by Type(K Units)
  • Table 99. Extracorporeal Membrane Oxygenation Machine Sales VA ECMO Machine , by Region K Units (2018-2023)
  • Table 100. Extracorporeal Membrane Oxygenation Machine Sales VV ECMO Machine , by Region K Units (2018-2023)
  • Table 101. Extracorporeal Membrane Oxygenation Machine Sales: by Application(K Units)
  • Table 102. Extracorporeal Membrane Oxygenation Machine Sales Congenital diaphragmatic hernia (CDH) , by Region K Units (2018-2023)
  • Table 103. Extracorporeal Membrane Oxygenation Machine Sales Birth defects of the heart , by Region K Units (2018-2023)
  • Table 104. Extracorporeal Membrane Oxygenation Machine Sales Meconium aspiration syndrome (MAS) , by Region K Units (2018-2023)
  • Table 105. Extracorporeal Membrane Oxygenation Machine Sales Severe pneumonia , by Region K Units (2018-2023)
  • Table 106. Extracorporeal Membrane Oxygenation Machine Sales Severe air leak problems , by Region K Units (2018-2023)
  • Table 107. Extracorporeal Membrane Oxygenation Machine Sales Severe high blood pressure in the arteries of the lungs (PPHN) , by Region K Units (2018-2023)
  • Table 108. Extracorporeal Membrane Oxygenation Machine Sales: by Patient Type(K Units)
  • Table 109. Extracorporeal Membrane Oxygenation Machine Sales Neonates , by Region K Units (2018-2023)
  • Table 110. Extracorporeal Membrane Oxygenation Machine Sales Pediatric , by Region K Units (2018-2023)
  • Table 111. Extracorporeal Membrane Oxygenation Machine Sales Adult , by Region K Units (2018-2023)
  • Table 112. South America Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2018-2023)
  • Table 113. South America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 114. South America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 115. South America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 116. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 117. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 118. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 119. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 120. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 121. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 122. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 123. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 124. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 125. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2018-2023)
  • Table 126. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 127. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 128. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 129. China Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 130. China Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 131. China Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 132. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 133. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 134. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 135. India Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 136. India Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 137. India Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 138. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 139. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 140. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 141. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 142. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 143. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 144. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 145. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 146. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 147. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 148. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 149. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 150. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2018-2023)
  • Table 151. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 152. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 153. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 154. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 155. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 156. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 157. France Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 158. France Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 159. France Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 160. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 161. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 162. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 163. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 164. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 165. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 166. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 167. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 168. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 169. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 170. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 171. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 172. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2018-2023)
  • Table 173. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 174. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 175. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 176. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 177. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 178. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 179. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 180. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 181. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 182. North America Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2018-2023)
  • Table 183. North America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 184. North America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 185. North America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 186. United States Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 187. United States Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 188. United States Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 189. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 190. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 191. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 192. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2018-2023)
  • Table 193. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2018-2023)
  • Table 194. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2018-2023)
  • Table 195. Extracorporeal Membrane Oxygenation Machine: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Extracorporeal Membrane Oxygenation Machine: by Type(USD Million)
  • Table 207. Extracorporeal Membrane Oxygenation Machine VA ECMO Machine , by Region USD Million (2025-2030)
  • Table 208. Extracorporeal Membrane Oxygenation Machine VV ECMO Machine , by Region USD Million (2025-2030)
  • Table 209. Extracorporeal Membrane Oxygenation Machine: by Application(USD Million)
  • Table 210. Extracorporeal Membrane Oxygenation Machine Congenital diaphragmatic hernia (CDH) , by Region USD Million (2025-2030)
  • Table 211. Extracorporeal Membrane Oxygenation Machine Birth defects of the heart , by Region USD Million (2025-2030)
  • Table 212. Extracorporeal Membrane Oxygenation Machine Meconium aspiration syndrome (MAS) , by Region USD Million (2025-2030)
  • Table 213. Extracorporeal Membrane Oxygenation Machine Severe pneumonia , by Region USD Million (2025-2030)
  • Table 214. Extracorporeal Membrane Oxygenation Machine Severe air leak problems , by Region USD Million (2025-2030)
  • Table 215. Extracorporeal Membrane Oxygenation Machine Severe high blood pressure in the arteries of the lungs (PPHN) , by Region USD Million (2025-2030)
  • Table 216. Extracorporeal Membrane Oxygenation Machine: by Patient Type(USD Million)
  • Table 217. Extracorporeal Membrane Oxygenation Machine Neonates , by Region USD Million (2025-2030)
  • Table 218. Extracorporeal Membrane Oxygenation Machine Pediatric , by Region USD Million (2025-2030)
  • Table 219. Extracorporeal Membrane Oxygenation Machine Adult , by Region USD Million (2025-2030)
  • Table 220. South America Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2025-2030)
  • Table 221. South America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 222. South America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 223. South America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 224. Brazil Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 225. Brazil Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 226. Brazil Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 227. Argentina Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 228. Argentina Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 229. Argentina Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 230. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 231. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 232. Rest of South America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 233. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2025-2030)
  • Table 234. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 235. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 236. Asia Pacific Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 237. China Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 238. China Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 239. China Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 240. Japan Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 241. Japan Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 242. Japan Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 243. India Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 244. India Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 245. India Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 246. South Korea Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 247. South Korea Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 248. South Korea Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 249. Taiwan Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 250. Taiwan Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 251. Taiwan Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 252. Australia Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 253. Australia Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 254. Australia Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 257. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 258. Europe Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2025-2030)
  • Table 259. Europe Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 260. Europe Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 261. Europe Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 262. Germany Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 263. Germany Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 264. Germany Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 265. France Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 266. France Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 267. France Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 268. Italy Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 269. Italy Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 270. Italy Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 271. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 272. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 273. United Kingdom Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 274. Netherlands Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 275. Netherlands Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 276. Netherlands Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 277. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 278. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 279. Rest of Europe Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 280. MEA Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2025-2030)
  • Table 281. MEA Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 282. MEA Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 283. MEA Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 284. Middle East Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 285. Middle East Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 286. Middle East Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 287. Africa Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 288. Africa Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 289. Africa Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 290. North America Extracorporeal Membrane Oxygenation Machine, by Country USD Million (2025-2030)
  • Table 291. North America Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 292. North America Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 293. North America Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 294. United States Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 295. United States Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 296. United States Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 297. Canada Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 298. Canada Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 299. Canada Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 300. Mexico Extracorporeal Membrane Oxygenation Machine, by Type USD Million (2025-2030)
  • Table 301. Mexico Extracorporeal Membrane Oxygenation Machine, by Application USD Million (2025-2030)
  • Table 302. Mexico Extracorporeal Membrane Oxygenation Machine, by Patient Type USD Million (2025-2030)
  • Table 303. Extracorporeal Membrane Oxygenation Machine Sales: by Type(K Units)
  • Table 304. Extracorporeal Membrane Oxygenation Machine Sales VA ECMO Machine , by Region K Units (2025-2030)
  • Table 305. Extracorporeal Membrane Oxygenation Machine Sales VV ECMO Machine , by Region K Units (2025-2030)
  • Table 306. Extracorporeal Membrane Oxygenation Machine Sales: by Application(K Units)
  • Table 307. Extracorporeal Membrane Oxygenation Machine Sales Congenital diaphragmatic hernia (CDH) , by Region K Units (2025-2030)
  • Table 308. Extracorporeal Membrane Oxygenation Machine Sales Birth defects of the heart , by Region K Units (2025-2030)
  • Table 309. Extracorporeal Membrane Oxygenation Machine Sales Meconium aspiration syndrome (MAS) , by Region K Units (2025-2030)
  • Table 310. Extracorporeal Membrane Oxygenation Machine Sales Severe pneumonia , by Region K Units (2025-2030)
  • Table 311. Extracorporeal Membrane Oxygenation Machine Sales Severe air leak problems , by Region K Units (2025-2030)
  • Table 312. Extracorporeal Membrane Oxygenation Machine Sales Severe high blood pressure in the arteries of the lungs (PPHN) , by Region K Units (2025-2030)
  • Table 313. Extracorporeal Membrane Oxygenation Machine Sales: by Patient Type(K Units)
  • Table 314. Extracorporeal Membrane Oxygenation Machine Sales Neonates , by Region K Units (2025-2030)
  • Table 315. Extracorporeal Membrane Oxygenation Machine Sales Pediatric , by Region K Units (2025-2030)
  • Table 316. Extracorporeal Membrane Oxygenation Machine Sales Adult , by Region K Units (2025-2030)
  • Table 317. South America Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2025-2030)
  • Table 318. South America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 319. South America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 320. South America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 321. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 322. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 323. Brazil Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 324. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 325. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 326. Argentina Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 327. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 328. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 329. Rest of South America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 330. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2025-2030)
  • Table 331. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 332. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 333. Asia Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 334. China Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 335. China Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 336. China Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 337. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 338. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 339. Japan Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 340. India Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 341. India Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 342. India Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 343. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 344. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 345. South Korea Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 346. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 347. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 348. Taiwan Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 349. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 350. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 351. Australia Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 352. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 353. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 354. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 355. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2025-2030)
  • Table 356. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 357. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 358. Europe Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 359. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 360. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 361. Germany Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 362. France Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 363. France Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 364. France Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 365. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 366. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 367. Italy Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 368. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 369. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 370. United Kingdom Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 371. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 372. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 373. Netherlands Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 374. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 375. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 376. Rest of Europe Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 377. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2025-2030)
  • Table 378. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 379. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 380. MEA Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 381. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 382. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 383. Middle East Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 384. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 385. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 386. Africa Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 387. North America Extracorporeal Membrane Oxygenation Machine Sales, by Country K Units (2025-2030)
  • Table 388. North America Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 389. North America Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 390. North America Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 391. United States Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 392. United States Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 393. United States Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 394. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 395. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 396. Canada Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 397. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Type K Units (2025-2030)
  • Table 398. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Application K Units (2025-2030)
  • Table 399. Mexico Extracorporeal Membrane Oxygenation Machine Sales, by Patient Type K Units (2025-2030)
  • Table 400. Extracorporeal Membrane Oxygenation Machine: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Extracorporeal Membrane Oxygenation Machine: by Type USD Million (2018-2023)
  • Figure 5. Global Extracorporeal Membrane Oxygenation Machine: by Application USD Million (2018-2023)
  • Figure 6. Global Extracorporeal Membrane Oxygenation Machine: by Patient Type USD Million (2018-2023)
  • Figure 7. South America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 8. Asia Pacific Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 9. Europe Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 10. MEA Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 11. North America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 12. Global Extracorporeal Membrane Oxygenation Machine: by Type K Units (2018-2023)
  • Figure 13. Global Extracorporeal Membrane Oxygenation Machine: by Application K Units (2018-2023)
  • Figure 14. Global Extracorporeal Membrane Oxygenation Machine: by Patient Type K Units (2018-2023)
  • Figure 15. South America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 16. Asia Pacific Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 17. Europe Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 18. MEA Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 19. North America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 20. Global Extracorporeal Membrane Oxygenation Machine: by Type USD/Units (2018-2023)
  • Figure 21. Global Extracorporeal Membrane Oxygenation Machine share by Players 2023 (%)
  • Figure 22. Global Extracorporeal Membrane Oxygenation Machine share by Players (Top 3) 2023(%)
  • Figure 23. Global Extracorporeal Membrane Oxygenation Machine share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 27. Getinge Group (Sweden) Revenue, Net Income and Gross profit
  • Figure 28. Getinge Group (Sweden) Revenue: by Geography 2023
  • Figure 29. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 31. LivaNova PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. LivaNova PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 33. XENIOS AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. XENIOS AG (Germany) Revenue: by Geography 2023
  • Figure 35. ALung Technologies, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 36. ALung Technologies, Inc. (Germany) Revenue: by Geography 2023
  • Figure 37. EUROSETS S.r.l. (Italy) Revenue, Net Income and Gross profit
  • Figure 38. EUROSETS S.r.l. (Italy) Revenue: by Geography 2023
  • Figure 39. MicroPort Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 40. MicroPort Scientific Corporation (China) Revenue: by Geography 2023
  • Figure 41. NIPRO Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 42. NIPRO Corporation (Japan) Revenue: by Geography 2023
  • Figure 43. OriGen Biomedical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. OriGen Biomedical, Inc. (United States) Revenue: by Geography 2023
  • Figure 45. Global Extracorporeal Membrane Oxygenation Machine: by Type USD Million (2025-2030)
  • Figure 46. Global Extracorporeal Membrane Oxygenation Machine: by Application USD Million (2025-2030)
  • Figure 47. Global Extracorporeal Membrane Oxygenation Machine: by Patient Type USD Million (2025-2030)
  • Figure 48. South America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 49. Asia Pacific Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 50. Europe Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 51. MEA Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 52. North America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 53. Global Extracorporeal Membrane Oxygenation Machine: by Type K Units (2025-2030)
  • Figure 54. Global Extracorporeal Membrane Oxygenation Machine: by Application K Units (2025-2030)
  • Figure 55. Global Extracorporeal Membrane Oxygenation Machine: by Patient Type K Units (2025-2030)
  • Figure 56. South America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 57. Asia Pacific Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 58. Europe Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 59. MEA Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 60. North America Extracorporeal Membrane Oxygenation Machine Share (%), by Country
  • Figure 61. Global Extracorporeal Membrane Oxygenation Machine: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Medtronic plc (Ireland)
  • Getinge Group (Sweden)
  • Terumo Corporation (Japan)
  • LivaNova PLC (United Kingdom)
  • XENIOS AG (Germany)
  • ALung Technologies, Inc. (Germany)
  • EUROSETS S.r.l. (Italy)
  • MicroPort Scientific Corporation (China)
  • NIPRO Corporation (Japan)
  • OriGen Biomedical, Inc. (United States)
Additional players considered in the study are as follows:
EUROSETS NIPRO (Japan) , MicroPort Scientific Corporation (China) , Maquet Holding GmbH & Co. KG (Germany) , Terumo Corporation (Japan) , LivaNova PLC (United Kingdom)
Select User Access Type

Key Highlights of Report


Jan 2024 247 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Extracorporeal Membrane Oxygenation Machine Quantitative research analysis
Global Extracorporeal Membrane Oxygenation Machine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic plc (Ireland), Getinge Group (Sweden), Terumo Corporation (Japan), LivaNova PLC (United Kingdom), XENIOS AG (Germany), ALung Technologies, Inc. (Germany), EUROSETS S.r.l. (Italy), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan) and OriGen Biomedical, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Demand for Portable ECMO Machine" is seen as one of major influencing trends for Extracorporeal Membrane Oxygenation Machine Market during projected period 2023-2030.
The Extracorporeal Membrane Oxygenation Machine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Extracorporeal Membrane Oxygenation Machine Report?

Have a Query? Click Here

Other Related Reports

Urology Surgical Instruments Comprehensive Study by Type (Urology Endoscopes, Endovision Systems, Peripheral Systems, Consumables and Accessories), Application (Chronic Kidney Disease, Urinary Stones...
$ 3750
Chest Drainage Catheters Comprehensive Study by Type (Regular Chest Drainage Catheters, Thoracentesis Catheters), Application (Clinics, Hospitals, Others), Chest drainage system (Two component, Three...
$ 3500
Physiological Sea Water Nasal Spray Comprehensive Study by Type (Isotonic, Hypertonic), End Users (Infants, Children, Adults), Indication (Cold Relief, Nasal Hygiene, Allergic Rhinitis, Sinusitis, Ot...
$ 1800
Digital Dental Impression Devices Comprehensive Study by Type (CEREC System, Lava C.O.S. system, ITero system, E4D, TRIOS), Application (Dental Clinic, Hospital, Others), Technology (Computer-Aided D...
$ 3350
Stethoscopes Comprehensive Study by Type (Manual & Mechanical Stethoscopes, Electronic Stethoscopes, Esophageal Stethoscopes, Fetal Stethoscopes, Fetal Heart Rate Detectors), Application (Hospitals, ...
$ 3650
Particulate Respirators Comprehensive Study by Type (Half Face, Full Face), Series (N-series, R-series, P-series), Technology (With Breather Valve, Without Breather Valve), Product (Mechanical Filter...
$ 3450